Long-Term Gastrointestinal Outcomes in Children Exposed in Utero to Maternal Chronic Hypertension

Nir Roguin1, Gil Gutvirtz1, Gali Pariente1

  • 1Department of Obstetrics and Gynaecology, Soroka University Medical Centre, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Insights

Maternal chronic hypertension was linked to reduced gastrointestinal (GI) issues in early childhood for offspring. However, this protective effect diminished over time, with no significant difference in GI morbidity observed in late adolescence.

Area of Science:

  • Obstetrics and Gynecology
  • Pediatric Gastroenterology
  • Public Health

Background:

  • Maternal hypertension is a known risk factor for adverse pregnancy outcomes.
  • Long-term effects on offspring gastrointestinal (GI) health are not well understood.
  • Chronic hypertension may impact fetal gut development via uteroplacental insufficiency and inflammation.

Purpose of the Study:

  • To determine if maternal chronic hypertension, independent of preeclampsia, is associated with long-term GI morbidity in offspring.
  • To investigate the temporal relationship between maternal hypertension and offspring GI health outcomes.

Main Methods:

  • Population-based retrospective cohort study (1991-2021) of singleton deliveries.
  • Offspring followed up to age 18 for GI diagnoses using ICD-9 codes.
  • Piecewise Poisson log-linear models used to estimate adjusted incidence rate ratios (IRR), controlling for confounders.

Main Results:

  • Among 342,635 deliveries, 0.9% involved mothers with chronic hypertension.
  • Offspring exposed to maternal chronic hypertension showed reduced GI risk in early childhood (adjusted IRR < 1 year: 0.34; 1-3 years: 0.46).
  • No significant difference in GI risk was observed in late adolescence (15-18 years: adjusted IRR 1.09).

Conclusions:

  • The association between maternal chronic hypertension and offspring GI morbidity is time-varying.
  • A protective effect on GI risk is observed in early childhood, which is not sustained into adolescence.
  • No long-term excess GI risk was identified in offspring exposed to maternal chronic hypertension.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.6K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.6K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
863
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
792